HIV impacts oral health. Infections and sores appear in the mouth. Canker sores and oral thrush are common. Oral hygiene is important for prevention. Antiretroviral therapy helps. Regular dental ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

WASHINGTON (AP) — The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028, the State Department announced Thursday.

MANILA, Philippines — According to the World Health Organization, the Human immunodeficiency virus (HIV) is a virus that attacks the body’s immune system. As HIV targets the body’s white blood cells, ...

ALBAY, Philippines – Decades ago, the fight against Human Immunodeficiency Virus (HIV) in Albay was marked by silence. Raising awareness about HIV, let alone getting tested, was seen as “filthy,” ...

JOHANNESBURG (AP) — On a warm evening in Johannesburg, the news spread like wildfire among sex workers: Within 24 hours, several nonprofit clinics providing free HIV services would be closing as ...

DESPITE major progress in treating HIV/AIDS in The Bahamas, stigma and discrimination continue to drive people to hide their status, health officials warned this week. At an HIV/AIDS educational ...

Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...

The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028 WASHINGTON -- The U.S. is purchasing enough doses of a new ...

Lenacapavir, marketed as Yeytuo, is approved for twice-yearly PrEP against HIV-1 in the EU, Norway, Iceland, and Liechtenstein. The European Medicines Agency's accelerated review led to the European ...